TY - JOUR
T1 - Assessment of beta blockade with propranolol
AU - Hager, W. David
AU - Pieniaszek, Henry J.
AU - Perrier, Donald
AU - Mayersohn, Michael
AU - Goldberger, Virginia
PY - 1981/9
Y1 - 1981/9
N2 - Each of seven subjects received on a weekly basis placebo or 10, 20, 40, 80, or 160 mg propanolol orally four times daily. The effect of propranolol on the resting heart rate and the heart rate response to the Valsalva maneuver, tilt, isoproterenol, and maximal exercise were measured. Coefficients of determination were calculated from the individual dose-response curves. The results indicate that the resting heart rate and the tachycardiac response to the Valsalva maneuver and tilt cannot be used to estimate beta blockade. Propranolol concentrations correlated well (mean r2 = 0.80) with the isoproterenol dose ratio minus one, but isoproterenol challenges appear clinically inapplicable. Reduction in maximal exercise tachycardia correlated best with propranolol concentrations (mean r2 = 0.89) but, to the extent that exercise could not be performed, there was no reliable way of clinically documenting beta blockade and only the serum concentration of propranolol was available as an indicator of appropriate therapy.
AB - Each of seven subjects received on a weekly basis placebo or 10, 20, 40, 80, or 160 mg propanolol orally four times daily. The effect of propranolol on the resting heart rate and the heart rate response to the Valsalva maneuver, tilt, isoproterenol, and maximal exercise were measured. Coefficients of determination were calculated from the individual dose-response curves. The results indicate that the resting heart rate and the tachycardiac response to the Valsalva maneuver and tilt cannot be used to estimate beta blockade. Propranolol concentrations correlated well (mean r2 = 0.80) with the isoproterenol dose ratio minus one, but isoproterenol challenges appear clinically inapplicable. Reduction in maximal exercise tachycardia correlated best with propranolol concentrations (mean r2 = 0.89) but, to the extent that exercise could not be performed, there was no reliable way of clinically documenting beta blockade and only the serum concentration of propranolol was available as an indicator of appropriate therapy.
UR - http://www.scopus.com/inward/record.url?scp=0019442342&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019442342&partnerID=8YFLogxK
U2 - 10.1038/clpt.1981.161
DO - 10.1038/clpt.1981.161
M3 - Article
C2 - 6115730
AN - SCOPUS:0019442342
SN - 0009-9236
VL - 30
SP - 283
EP - 290
JO - Clinical Pharmacology and Therapeutics
JF - Clinical Pharmacology and Therapeutics
IS - 3
ER -